ChemPartner Biologics

ChemPartner Biologics is a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) specializing in the discovery, development, and manufacture of biologic therapeutics. As a key division of Shanghai ChemPartner, the company offers an integrated service platform that supports clients from initial antibody discovery through to clinical-stage GMP production. Their technological expertise includes the Beacon optofluidic platform for B-cell cloning, phage display, and advanced protein engineering for complex modalities like bispecific antibodies and antibody-drug conjugates. With a strong presence in both China and the United States, ChemPartner Biologics serves a diverse range of global pharmaceutical and biotech partners. The company's comprehensive capabilities in cell line development and process optimization are designed to streamline the path to clinical trials for novel biologics.